LY-3541860
N/A
Report date: 2026/03/31 20:00:21
Base Information
Drug NameLY-3541860
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A